The enhanced anti-cancer effect of hexenyl ester of 5-aminolaevulinic acid photodynamic therapy in adriamycin-resistant compared to non-resistant breast cancer cells

Lasers in Surgery and Medicine

Volumn 44, Issue 1, 2012, Pages 76-86

  Yoon, Jung Hoon ^a   Yoon, Hyo Eun ^a   Kim, Ok ^a   Kim, Sang Kyum ^b   Ahn, Sang Gun ^a   Kang, Keon Wook ^c  

^a Chosun University   (South Korea)

^b Chungnam National University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

anti oxidant gene; chemotherapy resistance; Nrf2; protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; COMPLEMENTARY DNA; DOXORUBICIN; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE; RNA;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINOLEVULINIC ACID; APOPTOSIS; BREAST NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HEME OXYGENASE-1; HUMANS; IN SITU NICK-END LABELING; PHOTOCHEMOTHERAPY; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84862938646     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.21154     Document Type: Article

References (40)

1. Pérez-Tomás R,. Multidrug resistance: Retrospect and prospects in anti-cancer drug treatment. Curr Med Chem 2006; 13: 1859-1876.
2. Fairchild CR, Ivy SP, Kao-Shan CS, Whang-Peng J, Rosen N, Israel MA, Melera PW, Cowan KH, Goldsmith ME,. Isolation of amplified and overexpressed DNA sequences from adriamycin resistant human breast cancer cells. Cancer Res 1987; 47: 5141-5148. (Pubitemid 17146486)
3. Han CY, Cho KB, Choi HS, Han HK, Kang KW,. Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells. Carcinogenesis 2008; 29: 1837-1844.
4. Castanoa AP, Demidova TN, Hamblin MR,. Mechanisms in photodynamic therapy: Part one-photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther 2004; 1: 279-293. (Pubitemid 40460316)
5. Kelty CJ, Brown NJ, Reed MW, Ackroyd R,. The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis. Photochem Photobiol Sci 2002; 1: 158-168. (Pubitemid 37069724)
6. van den Akker JT, Iani V, Star WM, Sterenborg HJ, Moan J,. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: Differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum. Photochem Photobiol 2000; 72: 681-689.
7. Sharma S, Jajoo A, Dube A,. 5-Aminolevulinic acid-induced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines. J Photochem Photobiol B 2007; 88: 156-162. (Pubitemid 47382620)
8. Ito S, Miyoshi N, Degraff WG, Nagashima K, Kirschenbaum LJ, Riesz P,. Enhancement of 5-Aminolevulinic acid-induced oxidative stress on two cancer cell lines by gold nanoparticles. Free Radic Res 2009; 43: 1214-1224.
9. Diez B, Cordo Russo R, Teijo MJ, Hajos S, Batlle A, Fukuda H,. ROS production by endogenously generated Protoporphyrin IX in murine leukemia cells. Cell Mol Biol 2009; 55: 15-19.
10. Marti A, Jichlinski P, Lange N, Ballini JP, Guillou L, Leisinger HJ, Kucera P,. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. J Urol 2003; 170: 428-432. (Pubitemid 36870217)
11. Wu RW, Chu ES, Yow CM, Chen JY,. Photodynamic effects on nasopharyngeal carcinoma (NPC) cells with 5-aminolevulinic acid or its hexyl ester. Cancer Lett 2006; 242: 112-119. (Pubitemid 44485299)
12. Brunner H, Hausmann F, Knuechel R,. New 5-aminolevulinic acid esters-Efficient protoporphyrin precursors for photodetection and photodynamic therapy. Photochem Photobiol 2003; 78: 481-486.
13. Perotti C, Fukuda H, DiVenosa G, MacRobert AJ, Batlle A, Casas A,. Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies. Br J Cancer 2004; 90: 1660-1665. (Pubitemid 38648253)
14. Lee JB, Choi JY, Chun JS, Yun SJ, Lee SC, Oh J, Park HR,. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin. Br J Dermatol 2008; 159: 61-67. (Pubitemid 351874495)
15. Jo C, Jo YJ, Park HR, Lee JB, Kwon YH, Lee S, Chun KH, Oh J,. Synthesis and evaluation of unsaturated alkyl esters of 5-aminolevulinic acid as precursors to protoporphyrin IX. Bull Korean Chem Soc 2007; 28: 129-132. (Pubitemid 46168789)
16. Choi HK, Yang JW, Roh SH, Han CY, Kang KW,. Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells. Endocr Relat Cancer 2007; 14: 293-303. (Pubitemid 47242630)
17. Kim SK, Yang JW, Kim MR, Roh SH, Kim HG, Lee KY, Jeong HG, Kang KW,. Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells. Free Radic Biol Med 2008; 45: 537-546.
18. Nowis D, Makowski M, Stoklosa T, Legat M, Issat T, Golab J,. Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim Pol 2005; 52: 339-352. (Pubitemid 41133769)
19. Lu Z, Tao Y, Zhou Z, Zhang J, Li C, Ou L, Zhao B,. Mitochondrial reactive oxygen species and nitric oxide-mediated cancer cell apoptosis in 2-butylamino-2-demethoxyhypocrellin B photodynamic treatment. Free Radic Biol Med 2006; 41: 1590-1605. (Pubitemid 44528256)
20. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM,. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995; 81: 801-809.
21. Le Rhun Y, Kirkland JB, Shah GM,. Cellular responses to DNA damage in the absence of Poly(ADP-ribose) polymerase. Biochem Biophys Res Commun 1998; 1245: 1-10. (Pubitemid 28414236)
22. Hsieh YJ, Wu CC, Chang CJ, Yu JS,. Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: When plasma membranes are the main targets. J Cell Physiol 2003; 194: 363-375.
23. Hayes JD,. Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic Res 1995; 22: 193-207.
24. Anderson ME,. Glutathione: An overview of biosynthesis and modulation. Chem Biol Interact 1998; 24 (111-112): 1-14. (Pubitemid 28271929)
25. Mulcahy RT, Wartman MA, Bailey HH, Gipp JJ,. Constitutive and beta-naphthoflavone-induced expression of the human gamma-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J Biol Chem 1997; 272: 7445-7454. (Pubitemid 27166457)
26. Chan JY, Kwong M,. Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein. Biochim Biophys Acta 2000; 1517: 19-26.
27. Kang KW, Lee SJ, Park JW, Kim SG,. Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress. Mol Pharmacol 2002; 62: 1001-1010. (Pubitemid 35222491)
28. Itoh K, Ishii T, Wakabayashi N, Yamamoto M,. Regulatory mechanisms of cellular response to oxidative stress. Free Radic Res 1999; 31: 319-324. (Pubitemid 29452857)
29. Sinha AK, Anand S, Ortel BJ, Chang Y, Mai Z, Hasan T, Maytin EV,. Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer 2006; 95: 485-495. (Pubitemid 44232558)
30. Mesenhöller M, Matthews EK,. A key role for the mitochondrial benzodiazepine receptor in cellular photosensitisation with delta- aminolaevulinic acid. Eur J Pharmacol 2000; 406: 171-180.
31. Liu F, Xie ZH, Cai GP, Jiang YY,. The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells. Biol Pharm Bull 2007; 30: 2279-2283. (Pubitemid 350223727)
32. Ozben T,. Oxidative stress and apoptosis: Impact on cancer therapy. J Pharm Sci 2007; 96: 2181-2196. (Pubitemid 47477879)
33. Ling V,. Multidrug resistance: Molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 1997; 40: S3-S8.
34. Sharom FJ,. ABC multidrug transporters: Structure, function and role in chemoresistance. Pharmacogenomics 2008; 9: 105-127. (Pubitemid 351560534)
35. Girotti AW,. Photodynamic lipid peroxidation in biological systems. Photochem Photobiol 1990; 51: 497-509.
36. Henderson BW, Dougherty TJ,. How does photodynamic therapy work? Photochem Photobiol 1992; 55: 145-157.
37. Meister A, Anderson ME,. Glutathione. Annu Rev Biochem 1983; 52: 711-760. (Pubitemid 13030692)
38. Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, Yamamoto M,. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 2000; 275: 16023-16029. (Pubitemid 30366908)
39. McMahon M, Itoh K, Yamamoto M, Chanas SA, Henderson CJ, McLellan LI, Wolf CR, Cavin C, Hayes JD,. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 2001; 61: 3299-3307. (Pubitemid 32695017)
40. Taketani S, Furukawa T, Furuyama K,. Expression of coproporphyrinogen oxidase and synthesis of hemoglobin in human erythroleukemia K562 cells. Eur J Biochem 2001; 268: 1705-1711. (Pubitemid 32862705)